Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.5.1.52 (
PNGase F
)
1,527
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The
GLP-1 receptor
on RINm5F cells is a glycoprotein with a M(r) of 63,000. Treatment of the receptor with
glycopeptidase
F generated a protein with a M(r) of 51,000, indicating that the
GLP-1 receptor
contains N-linked glycans. Tunicamycin pretreatment concentration-dependently decreased GLP-1 binding to RINm5F cells due to a decreased receptor number without change of receptor affinity. Tunicamycin exerted no effect on the
GLP-1 receptor
mRNA expression. The stimulation of cAMP production was decreased in tunicamycin-treated cells. Our data show that glycosylation of the
GLP-1 receptor
is a precondition for regular receptor function.
...
PMID:Glycosylation of the GLP-1 receptor is a prerequisite for regular receptor function. 793 45